Disease Markers

Human Papillomaviruses and Cervical Cancer


Status
Published


Human Papillomaviruses and Cervical Cancer

Articles

  • Special Issue
  • - Volume 23
  • - Article ID 613150

Papillomavirus Life Cycle Organization and Biomarker Selection

John Doorbar
  • Special Issue
  • - Volume 23
  • - Article ID 461364
  • - Foreword

Foreword

Magnus von Knebel Doeberitz | Nicolas Wentzensen
  • Special Issue
  • - Volume 23
  • - Article ID 678793

Biomarkers in Cervical Cancer Screening

Nicolas Wentzensen | Magnus von Knebel Doeberitz
  • Special Issue
  • - Volume 23
  • - Article ID 942650

Human Papillomaviruses and Non-Melanoma Skin Cancer: Basic Virology and Clinical Manifestations

Ingo Nindl | Marc Gottschling | Eggert Stockfleth
  • Special Issue
  • - Volume 23
  • - Article ID 939634

A Long Way: History of the Prophylactic Papillomavirus Vaccine

Martin Müller | Lutz Gissmann
  • Special Issue
  • - Volume 23
  • - Article ID 591826

International Standard Reagents for HPV Detection

Sonia R. Pagliusi | Suzanne M. Garland
  • Special Issue
  • - Volume 23
  • - Article ID 914823

The Epidemiology of Human Papillomavirus Infection and Cervical Cancer

F. Xavier Bosch | Silvia de Sanjosé
  • Special Issue
  • - Volume 23
  • - Article ID 913761

Genital HPVs in the Aerodigestive Tract: Etiologic Association with a Subset of Oropharyngeal/Tonsillar Cancers and with Recurrent Respiratory Papillomatosis

Keerti V. Shah | William H. Westra
  • Special Issue
  • - Volume 23
  • - Article ID 136906

HPV Infections in Adolescents

Anna-Barbara Moscicki
  • Special Issue
  • - Volume 23
  • - Article ID 159137

HPV Infection in Men

Joel M. Palefsky
Disease Markers
 Journal metrics
Acceptance rate34%
Submission to final decision88 days
Acceptance to publication43 days
CiteScore3.500
Impact Factor2.738
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.